PRIA Logo™
116-hr-7722116th Congress

Matt’s Act

Sponsored By: Representative Fortenberry, Jeff [R-NE-1]

Unknown

Summary

Matt's Act This bill limits the amount that private health insurance plans may charge plan holders for insulin drugs to a maximum of $20, or $0 for high deductible plans; pharmacies may charge an uninsured individual who has diabetes the average net price of such drugs after deducting any rebates and discounts provided by drug manufacturers, plus limited additional charges for distributing and dispensing costs.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Fortenberry, Jeff [R-NE-1]

NE • R

Cosponsors

  • Rep. Craig, Angie [D-MN-2]

    MN • D

    Sponsored 7/22/2020

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation